Suspended – sale of drug to treat IBS

  • Nation
  • Tuesday, 03 Apr 2007

PETALING JAYA: The import and sale of adrug used to treat women with abdominalpain and constipation associated with irritablebowel syndrome (IBS) has been suspendedwith immediate effect. 

The medication Zelmac (tegaserod maleate),which is marketed in the United States underthe brand name Zelnorm, has been found bythe Food and Drug Administration (FDA) tocause a higher incidence of cardiovascularevents, according to a press statement by theHealth Ministry’s Drug Control Authority(DCA) yesterday. 

Zelnorm was taken off the US market recently.The suspension would be in effect until furtherinformation was obtained, said the ministry’sdirector-general Tan Sri Dr Ismail Merican. 

The statement also said that NovartisCorporation (M) Sdn Bhd, which has suspendedthe import and sale of Zelmac had advisedpatients being treated with the medication toseek alternative treatment for their condition.

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 1
Cxense type: free
User access status: 3
Join our Telegram channel to get our Evening Alerts and breaking news highlights

Next In Nation

Melaka Polls: Umno, BN should be ready to face elections by themselves if no coalitions willing to cooperate, says Najib
PM: Yayasan Keluarga Malaysia set up to support Malaysian children orphaned by Covid-19
Jeffrey Kitingan: Sabah assembly the right avenue to discuss amendments to Federal Constitution
Girl, 17, detained to assist with investigations into discovery of baby girl's body
Three-year-old boy feared drowned after falling into Sg Tawau
Covid-19 watch: Singapore places Malaysia under Category III
Melaka Polls: Norhizam to announce which party he will contest for in 48 hours
Melaka Polls: State DAP says will defend Pengkalan Batu seat
Covid-19: Two new workplace clusters detected, contributing 29 out of 5,828 new infections
Covid-19: Death of 14-year-old not linked to vaccine jab, says Johor Health Dept

Others Also Read